Research Topics
| Susan Cu-UvinSummaryAffiliation: Rhode Island Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCRWilliam T Seaman
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA
Virol J 7:194. 2010..While other quantitative PCR (qPCR) assays detect oncogenic HPV, there is no single tube assay distinguishing the most frequent oncogenic types and the most common types found in warts...
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNAS Cu-Uvin
Brown University, Providence, RI, USA
AIDS 14:415-21. 2000..To compare the effect of initiating HAART on the timing of HIV-1 RNA suppression in the blood plasma and genital tract among antiretroviral-naïve women...- Brown's involvement in the health of less developed countriesSusan Cu-Uvin
Immunology Center, Miriam Hospital, Providence, RI 02906, USA
Med Health R I 90:340-1. 2007 - Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 monthsSusan Cu-Uvin
The Miriam Hospital, Brown Medical School, Providence, Rhode Island, USA
J Acquir Immune Defic Syndr 42:584-7. 2006..To determine the patterns and predictors of genital tract HIV-1 RNA levels during a 36-month period... 
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral loadSusan Cu-Uvin
Division of Infectious Diseases, Department of Medicine, Miriam Hospital Alpert Medical School, Brown University, Providence, Rhode Island 02906, USA
AIDS 24:2489-97. 2010..Few studies have assessed longitudinal genital tract HIV-1 shedding. We determined patterns of genital tract HIV-1 RNA shedding over time among women with suppressed plasma viral load (PVL) on antiretroviral treatment...- Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tractS Cu-Uvin
Department of Obstetrics and Gynecology, Brown University, Providence, RI 02906, USA
Clin Infect Dis 33:894-6. 2001..Bacterial vaginosis was significantly associated with HIV-1 RNA expression in the female genital tract of HIV-infected women... - Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infectionSusan Cu-Uvin
Brown University, Providence, RI, USA
Clin Infect Dis 34:1406-11. 2002..HIV infection does not make a woman more likely to have prevalent, incident, or persistent or recurrent trichomoniasis... - Outcomes after treatment of cervical intraepithelial neoplasia among women with HIVL Stewart Massad
Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
J Low Genit Tract Dis 11:90-7. 2007..To describe outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV... - Effect of trichomoniasis therapy on genital HIV viral burden among African womenBrenna L Anderson
Department of Obstetrics and Gynecology, Women and Infants Hospital Alpert Medical School at Brown University, Providence, RI 02905, USA
Sex Transm Dis 39:638-42. 2012..Our objective was to test the hypothesis that treatment for trichomoniasis among HIV-infected women not taking antiretrovirals in South Africa would be associated with decreased HIV genital shedding... - Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosisCaroline Mitchell
Department of Obstetrics and Gynecology, University of Washington, P O Box 356460, Seattle, WA 98195, USA
Infect Dis Obstet Gynecol 2009:236919. 2009..Fastidious bacteria have been associated with bacterial vaginosis (BV) using PCR methods. We assessed the prevalence of these bacteria in HIV-1 infected women and their relationship with vaginal pH and shedding of HIV-1 RNA... - HIV infection in refugees: a case-control analysis of refugees in Rhode IslandCurt G Beckwith
The Miriam Hospital, Providence, Rhode Island, USA
Int J Infect Dis 13:186-92. 2009..We performed a retrospective case-control analysis of HIV-infected refugees in order to characterize their co-morbidities, baseline HIV characteristics, and longitudinal care compared to HIV-infected non-refugees... - High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral sheddingRegan N Theiler
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77550 0587, USA
Obstet Gynecol 115:1150-8. 2010..To evaluate the presence of and estimate risk factors for reactivation of latent high-risk human papillomavirus (HPV) cervical infection in human immunodeficiency virus (HIV)-infected and HIV-uninfected women... - Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherenceJoseph I Harwell
Brown University, Providence, RI, USA
AIDS 17:1990-3. 2003..6 log10 copies/ml) CVL HIV-1-RNA levels by 3 months and undetectable plasma HIV-1-RNA levels by 6 months. The mean CD4 cell increase was 76 cells/mm3. DOT appears effective and may reduce infectiousness in this high-risk population... - Genital tract leukocytes and shedding of genital HIV type 1 RNABrenna L Anderson
Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI 02905, USA
Clin Infect Dis 47:1216-21. 2008..We sought to determine whether the presence of inflammatory cells in the vagina is associated with the presence of genital tract HIV type 1 (HIV-1) RNA... - In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant womenBrenna L Anderson
Department of Obstetrics and Gynecology, Alpert School of Medicine, Brown University Women and Infants Hospital, Providence, RI, USA
Am J Obstet Gynecol 207:65.e1-10. 2012..To evaluate whether cervicovaginal secretions inhibit HIV-1 infectivity in an in vitro model, and estimate concentration of immune mediators... - Special care issues of women living with HIV-AIDSErna Milunka Kojic
Division of Infectious Diseases, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02806, USA
Infect Dis Clin North Am 21:133-48, ix. 2007..More women are expected to reach menopause. Health care providers should be aware of these unique needs of HIV-infected women... - Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected womenPhyllis Losikoff
Department of Pediatrics, Division of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA
Infect Dis Obstet Gynecol 2007:92307. 2007..Trends in cytokine levels were similar for HIV-infected and HIV-uninfected women. BV in these women was associated with significantly higher concentrations of genital tract IL-8 which decreased 2.4 fold when BV was cleared... - Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?Timothy P Flanigan
Department of Medicine, Brown University, Providence, RI 02906, USA
Clin Infect Dis 45:1499-501. 2007 - Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapyAwewura Kwara
Miriam Hospital, Providence, Rhode Island 02906, USA
Clin Infect Dis 46:719-25. 2008.... - A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicideJoseph I Harwell
Brown University, The Miriam Hospital, Providence, Rhode Island 02906, USA
J Womens Health (Larchmt) 12:255-9. 2003..We undertook a pilot study of a buffering vaginal microbicide in the treatment of BV... - The changing face of HIV in pregnancy in Rhode Island 2004-2009Jacqueline Firth
Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA
Infect Dis Obstet Gynecol 2012:895047. 2012.... - HIV and menopause: a reviewErna Milunka Kojic
Department of Medicine, Division of Infectious Diseases, The Miriam Hospital, Brown University, Providence, Rhode Island 02906, USA
J Womens Health (Larchmt) 16:1402-11. 2007..Likewise, there is a need for a better understanding of the prevalence and manifestations of depression among these women... - Infant outcomes after maternal antiretroviral exposure in resource-limited settingsKarin Nielsen-Saines
Department of Pediatrics, Division of Infectious Diseases, David Geffen UCLA School of Medicine, MDCC 22 442, 10833 LeConte Ave, Los Angeles, CA 90095, USA
Pediatrics 129:e1525-32. 2012..The impact of maternal antiretrovirals (ARVs) during pregnancy, labor, and postpartum on infant outcomes is unclear... - Antiretroviral-induced hepatotoxicity presenting as nonreassuring fetal testingNadine Kassis
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women and Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
Obstet Gynecol 116:515-7. 2010..Treatment can cause mitochondrial dysfunction, leading to liver damage and acidosis. Early diagnosis is essential to improve outcome... - Effect of the menstrual cycle on virological parametersSusan Cu-Uvin
Brown University, Providence, RI, USA
J Acquir Immune Defic Syndr 38:S33-4. 2005 - Update: human papillomavirus infection remains highly prevalent and persistent among HIV-infected individualsErna Milunka Kojic
Department of Medicine, Division of Infectious Diseases, The Miriam Hospital, and Department of Obstetrics and Gynecology, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island 02906, USA
Curr Opin Oncol 19:464-9. 2007.... - Pregnancy-induced changes in immune protection of the genital tract: defining normalBrenna L Anderson
Division of Maternal Fetal Medicine, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI
Am J Obstet Gynecol 208:321.e1-9. 2013..The objective of this study was to define immune changes in lower genital and systemic immunity associated with normal pregnancy... - HIV-1 seroprevalence and awareness of mother-to-child transmission issues among women seeking antenatal care in Tamil Nadu, IndiaJacqueline Firth
Department of Medicine, Warren Alpert Medical School at Brown University, Providence, RI, USA
J Int Assoc Physicians AIDS Care (Chic) 9:206-13. 2010..Conclusions: There is a need to educate South Indian women about HIV to give them information and the means to protect themselves and their unborn children from acquiring HIV... - Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytologyLori A Boardman
Women and Infants Hospital of Rhode Island and The Miriam Hospital, Brown University, Providence, Rhode Island, USA
Obstet Gynecol 112:238-43. 2008..To compare the prevalence of cervical intraepithelial neoplasia (CIN) 2 or worse in a cohort of human immunodeficiency virus (HIV)-positive and HIV-negative women with mildly abnormal cervical cytology... - Antiretroviral rounds. Can you be positive that she's positive?Susan Cu-Uvin
Brown University School of Medicine, Providence, Rhode Island, USA
AIDS Clin Care 16:98-9. 2004 - Pregnancy and optimal care of HIV-infected patientsBrenna L Anderson
Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, Rhode Island, USA
Clin Infect Dis 48:449-55. 2009..In these settings, exclusive breast-feeding for 6 months is recommended to reduce the risk of postnatal transmission... - Clinical parameters essential to methodology and interpretation of mucosal responsesBrenna L Anderson
Department of Obstetrics and Gynecology, Women and Infant s Hospital, Alpert Medical School at Brown University, 101 Dudley Street, Providence, RI 02905, USA
Am J Reprod Immunol 65:352-60. 2011..Important topics to consider include the method and source of sample collection, the individual patient characteristics, and in the case of recruitment of HIV-infected women, HIV disease characteristics... - Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant womenBrenna L Anderson
Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Providence, RI, USA
Acta Obstet Gynecol Scand 90:510-5. 2011..The objective of this study was to examine the impact of changes in individual microflora on genital immunity among low-risk pregnant women in early pregnancy... - Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1Selvi B Williams
Department of Medicine, Brown University School of Medicine, Providence, RI 02906, USA
Clin Infect Dis 35:611-7. 2002..0474) compared with women who did not have bacterial vaginosis. Enhanced understanding of correlates of mucosal immunity to HIV-1 may assist in the design of vaccine strategies or in the prevention of vertical transmission of HIV-1... - Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in womenKartik K Venkatesh
Department of Obstetrics and Gynecology, Alpert Medical School, Brown University, Providence, RI 02912, USA
Am J Reprod Immunol 69:68-73. 2013..The reasons for these divergent results still remain to be fully elucidated. Understanding biological factors that affect HIV susceptibility provide opportunities to identify prevention strategies to reduce the risk of HIV acquisition... - Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and EfavirenzMonica L Carten
Division of Infectious Diseases, University of Colorado Denver, Aurora, CO, USA
Infect Dis Obstet Gynecol 2012:137192. 2012..Compare the Plan B levonorgestrel (LNG) area under the concentration- time curve (AUC(12)) prior to and with efavirenz (EFV). Design. Prospective, open-label, single-arm, equivalence study... - Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western KenyaHillary Mabeya
United States Agency for International Development Academic Model Providing Access to Healthcare Partnership, Moi University School of Medicine, Eldoret, Kenya
J Low Genit Tract Dis 16:92-7. 2012..This study aimed to determine the accuracy of visual inspection with acetic acid (VIA) versus conventional Pap smear as a screening tool for cervical intraepithelial neoplasia/cancer among human immunodeficiency virus (HIV)-infected women... - Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic
Department of Medicine, Division of Infectious Diseases, Miriam Hospital, The Alpert Medical School of Brown University, Providence, RI 02906, USA
Sex Transm Dis 38:253-9. 2011..Human papillomavirus (HPV) infection of the cervix and related abnormal cervical cytology in HIV-infected women has been well described. Little is known about anal HPV infection in HIV-infected women... - Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infectionDenise J Jamieson
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Am J Obstet Gynecol 186:21-7. 2002.... - The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretionsPatricia S Reichelderfer
J Infect Dis 186:726-8; author reply 728-9. 2002 - Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cyclePamela A Kozlowski
GI Cell Biology Research Laboratory, Children s Hospital, and Department of Pediatrics, Harvard University, Boston, MA 02115, USA
J Immunol 169:566-74. 2002..However, induction of genital tract and rectal Ab responses of the magnitude generated by local V-FP(imm) or R(imm) will likely require administration of comparably high nasal vaccine dosages... - Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severityAnn Duerr
National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health HIV Section, Centers for Disease Control and Prevention, Mailstop K 34, 4770 Buford Highway NE, Atlanta, GA 30341 3717, USA
Obstet Gynecol 101:548-56. 2003..To examine risk factors for vulvovaginal candidiasis among women with or at risk for human immunodeficiency virus (HIV) infection... - The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital wartsMichael J Silverberg
Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
Sex Transm Dis 29:427-35. 2002..CONCLUSIONS: HIV infection and immunodeficiency synergistically modified the relation between HPV 6 or 11 infection and genital wart prevalence... - Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virusSioban D Harlow
Department of Epidemiology, University of Michigan, Ann Arbor, USA
Am J Obstet Gynecol 188:881-6. 2003..The purpose of this study was to evaluate the impact of substance use and psychotherapeutic medications on menstrual characteristics in women who are human immunodeficiency virus seropositive and seronegative... - Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative womenPaula Schuman
Wayne State University School of Medicine, Detroit, Michigan 48109, USA
J Infect Dis 188:128-36. 2003..SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated... - Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative womenRaphael P Viscidi
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Infect Dis 187:194-205. 2003..Despite the higher prevalence of HPV infection in this group, most HIV-positive women are able to control HPV-16 replication at the cervix, and reactivation, if it occurs, is not very common... - Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive womenHoward D Strickler
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
J Natl Cancer Inst 95:1062-71. 2003..To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS)... - Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068Jeffrey M Jacobson
Beth Israel Medical Center and Albert Einstein College of Medicine, New York, NY 10003, USA
J Infect Dis 194:623-32. 2006.... - Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative womenJill Koshiol
Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, USA
Am J Epidemiol 164:176-83. 2006..93, 95% CI: 0.68, 1.26) women. HPV clearance did not appear to vary by amount or duration of smoking. Smoking did not modify overall clearance but was associated with lower high-risk HPV clearance in HIV-seronegative women... - Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infectionBeth C Tohill
Centers for Disease Control and Prevention, National Center for Chronic Disease and Public Health Prevention, Division of Nutrition and Physical Activity and Division of Reproductive Health, Atlanta, GA 30341, USA
Am J Clin Nutr 85:1327-34. 2007..This relation among HIV, nutrition, and gynecological conditions is complex and has rarely been investigated... - Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virusDenise J Jamieson
Womens Health and Fertility Branch, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Obstet Gynecol 107:1023-8. 2006..To compare the incidence of vulvar, vaginal, and perianal intraepithelial neoplasia among human immunodeficiency virus (HIV)-infected women with a group of well-matched high-risk HIV-uninfected controls... - Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndromeNancy M Brim
Brigham and Women s Hospital, Boston, Massachusetts, USA
AIDS Read 17:322-8, C3. 2007.... - Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatusJill E Koshiol
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
Int J Cancer 119:1623-9. 2006..57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus... - Protease inhibitor use in 233 pregnanciesAnne B Morris
Community Research Initiative of New England, Springfield, MA 01107, USA
J Acquir Immune Defic Syndr 40:30-3. 2005..Prospective trials employing HAART during pregnancy are ongoing... - Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infectionBeth C Tohill
Centers for Disease Control and Prevention, National Center for Chronic Disease and Public Health Prevention, Division of Nutrition and Physical Activity, Atlanta, GA 30341, USA
Infect Dis Obstet Gynecol 12:121-6. 2004..The proposed profiles from the Gram stain reflect the morphotypic categories describing vaginal flora that may enable clearer elucidation of gynecologic and obstetric outcomes in various populations... - Prevalence and persistence of nonnucleoside reverse transcriptase inhibitor mutations in the female genital tractMichael Newstein
J Acquir Immune Defic Syndr 38:364-6. 2005 - Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative womenRaphael P Viscidi
Johns Hopkins Hospital, Blalock Room 1105, 600 North Wolfe Street, Baltimore, MD 21287, USA
Cancer Epidemiol Biomarkers Prev 14:283-8. 2005..0-2.0). The lack of a protective immune effect from natural infection is most likely due to the low level of antibody elicited by natural HPV infection and/or the potential for reactivation of HPV, especially in HIV-positive women... - HIV and obstetric complications and fetal outcomes in Vellore, IndiaJessie Lionel
Department of Obstetrics and Gynaecology, Christian Medical College, Vellore, India
Trop Doct 38:144-6. 2008..001). HIV prophylaxis and optimal prenatal care should be a priority for HIV-infected pregnant women in resource-limited countries... - Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected womenSherene S Min
Schools of Medicine, University of North Carolina, Chapel Hill 27599-7360, USA
J Acquir Immune Defic Syndr 37:1577-80. 2004..Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary... - Effect of HIV infection on atypical squamous cells of undetermined significanceAnn Duerr
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Clin Infect Dis 42:855-61. 2006..Detection of atypical squamous cells of undetermined significance (ASCUS) is a cervical cytologic finding that is suggestive but not definitive of squamous intraepithelial lesions (SILs)... - Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cellsMarie Larsson
Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, NY, USA
AIDS 16:171-80. 2002.... - T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected womenAlison J Quayle
Department of Immunology, Microbiology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
J Acquir Immune Defic Syndr 44:292-8. 2007..The mucosal lymphocyte population is the largest in the body, and the gastrointestinal compartment has been well characterized in HIV infection. Much less is known about the effects of HIV on the genital tract... - Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomyPangaja Paramsothy
Contraceptive Research and Development (CONRAD) Program, Arlington, VA, USA
J Acquir Immune Defic Syndr 35:484-91. 2004....
Research Grants
- ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMENSusan Cu Uvin; Fiscal Year: 2007..These findings underscore the risk of spreading resistant HIV-1 variants sexually as well as perinatally. With my research, I hope to be able to help contribute to the work on HIV treatment and prevention. ..
- ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMENSusan Cu Uvin; Fiscal Year: 2007..We also propose to enroll women who have undergone total hysterectomy to assess HIV dynamics in the vagina. ..
- ANTIVIRAL THERAPY AND HIV IN THE GENITAL TRACT OF WOMENSusan Cu Uvin; Fiscal Year: 2001..HIV load will be measured in plasma and cervicovaginal secretions by NASBA. HIV resistance phenotype will be determined by combined approaches of isolate phenotyping and genotyping of proviral DNA predominately in viral isolates. ..